Gavi, the Vaccine Alliance has partnered Seedstars to launch INFUSE 2024, a global call for applications for innovations to bolster health systems against climate threats and enhance immunisation delivery.
Seedstars is a Switzerland-based company with a mission to impact people’s lives in emerging markets through technology and entrepreneurship, while Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world’s deadliest diseases.
INFUSE, short for “Innovation for Uptake, Scale, and Equity in Immunisation”, is a Gavi-led initiative designed to scale up groundbreaking global health solutions by connecting high-impact, proven innovations where countries need them most.
The programme aims to select and scale innovations that contribute to low-carbon and sustainable resilient healthcare systems, enhance frontline health workers’ capacity to manage climate-related health threats and ensure efficient vaccine distribution under challenging climate conditions.
“The climate crisis has significant implications for vaccine preventable diseases and immunisation programmes. INFUSE is a great platform to mobilise the latest innovations in support of the health community to drive adaptive and mitigative actions against climate change,” said Augustin Flory, managing director for innovative partnerships and development finance at Gavi.
Sheilla Atieno, Seedstars programme manager for Africa, said the collaboration with Gavi for INFUSE 2024 was crucial in the fight against the health impacts of climate change.
“We are calling on innovators globally to come forward with solutions that can make a tangible difference in building climate-resilient health systems,” she said.
Applications are open here.
